-

Trinity Life Sciences Acquires D Cube Analytics

Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.

“Our strategy to revolutionize the life sciences commercial model includes embracing data science. D Cube brings us high-value, innovative technology platforms that will allow our clients to accelerate their brand strategies,” said David Fitzhenry, CEO of Trinity Life Sciences. “We are excited to add the D Cube team and their best-in-class offerings to our business.”

“The amount of innovation in the life sciences analytics space for the commercialization of products is growing at an exponential rate,” said Neal Dunn, Senior Partner, Analytics. “The D Cube acquisition allows Trinity to accelerate our already growing analytics practice with more deployable technology and proven machine learning models. It also provides Trinity with the scale and tools to help our clients shape and define how and when they should use analytics in a meaningful way – strong analytics will be key to all successful brands."

“The synergies that D Cube and Trinity share are clear,” said Vijay Nandakumar, co-founder and CEO of D Cube Analytics. “Life sciences companies are at the cusp of a data science revolution where the needs go far beyond clean, transparent and easy-to-manage data. The focus is on insights and speed of responsiveness to market dynamics. Our suite of capabilities combined with Trinity’s strategic therapeutic and commercial expertise offer clients the total package.”

“It was important for us to find a company that had a similar culture as D Cube Analytics and put clients first. Trinity’s purpose – every decision impacts a life – really spoke to us and aligned with our goals,” said Dr. Ajay Chandhok, co-founder and President of D Cube Analytics. “We all know why we get up in the morning – to help life sciences companies make decisions that bring successful life-changing and life-saving treatments to market.”

D Cube Analytics deploys data and cloud agnostic technology that allows life sciences companies not only to integrate, manage and analyze their data but also to focus on quick insights-based decision-making to effectively achieve business outcomes.

With 250+ employees, D Cube Analytics’ senior leadership (including Mr. Nandakumar and Dr. Chandhok) and staff will remain on with Trinity. The acquisition significantly expands Trinity’s India footprint, adding offices in Bengaluru and Chennai.

William Blair acted as exclusive financial advisor, Burke Warren acted as legal counsel and Vertices Partners acted as India Counsel for D Cube Analytics.

About D Cube Analytics
D Cube Analytics supports commercial leaders, digital transformation leaders, brand managers and other functional leads on their journey from data to commercial insights. The company leverages cutting edge technology, AI/ML and deep industry expertise to provide the analytics, insights and outcomes necessary to develop a deep understanding of patients, physicians and payers and build a superior commercial and clinical value proposition in the market. D Cube Analytics offers end-to-end biopharma data and analytics solutions. Their products, applications and services drive unparalleled commercial insights for life sciences companies. D Cube platforms include DDS Terra™, DDS IRIS™, DDS Unity™, DDS Cosmos™ and the newly launched DDS Commercial Insights Cloud™.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Life Sciences’ AI Algorithm Accurately Predicts Revenue Outcomes for Over 90% of U.S. Drug Launches Far Exceeding Wall Street Analyst Attempts

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, introduced its artificial intelligence (AI) algorithm which accurately predicted revenue outcomes for over 90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%). Trinity’s latest white paper in its Industry Impact Series, titled Predicting Winners: AI-Powered Portfolio Management, explores the use...

Health Equity Considerations as a Differentiator in Value Narratives Provide Opportunity for Life Sciences’ Global HTA Submissions

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces a dedicated Value Center of Excellence (COE) that provides end-to-end partnership along the value journey to Market Access and Health Economics and Outcomes Research (HEOR) teams, from strategy to communication. The COE approaches U.S. and global value work through a uniquely integrated combination of market access and HEOR expertise. Trinity’s Value C...

Analysis of Disparate Health Technology Assessment Landscape Transformed With Generative AI Tools

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, today announces an enhancement to its HTA Vision offering that swiftly extracts relevant information from health technology assessments (HTAs) and Trinity expert analyses, streamlining the information-gathering process within any therapeutic area or drug class. By not only locating but also summarizing key information with generative AI (GenAI), HTA Vision trans...
Back to Newsroom